GoodRx Holdings, Inc. (GDRX)
- Previous Close
8.55 - Open
8.70 - Bid 8.90 x 700
- Ask 8.96 x 100
- Day's Range
8.64 - 8.94 - 52 Week Range
4.14 - 9.37 - Volume
1,241,678 - Avg. Volume
1,299,731 - Market Cap (intraday)
3.343B - Beta (5Y Monthly) 1.40
- PE Ratio (TTM)
-- - EPS (TTM)
-0.01 - Earnings Date Aug 7, 2024 - Aug 12, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
9.49
GoodRx Holdings, Inc., together with its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices. It also offers other healthcare products and services, including subscriptions, and pharma manufacturer solutions, as well as telehealth services through the GoodRx Care platform. It serves pharmacy benefit managers who manage formularies and prescription transactions, including establishing pricing between consumers and pharmacies. The company was founded in 2011 and is headquartered in Santa Monica, California.
www.goodrx.com694
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: GDRX
Performance Overview: GDRX
Trailing total returns as of 6/10/2024, which may include dividends or other distributions. Benchmark is
.YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: GDRX
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: GDRX
Valuation Measures
Market Cap
3.35B
Enterprise Value
3.52B
Trailing P/E
--
Forward P/E
27.93
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
4.72
Price/Book (mrq)
5.30
Enterprise Value/Revenue
4.61
Enterprise Value/EBITDA
32.62
Financial Highlights
Profitability and Income Statement
Profit Margin
-0.86%
Return on Assets (ttm)
2.41%
Return on Equity (ttm)
-0.90%
Revenue (ttm)
764.16M
Net Income Avi to Common (ttm)
-6.59M
Diluted EPS (ttm)
-0.01
Balance Sheet and Cash Flow
Total Cash (mrq)
533.3M
Total Debt/Equity (mrq)
112.54%
Levered Free Cash Flow (ttm)
98.82M
Research Analysis: GDRX
Company Insights: GDRX
GDRX does not have Company Insights
Research Reports: GDRX
Dropping Coverage of GoodRx
GoodRx is a consumer-focused digital healthcare platform that aims to lower the cost of healthcare in the United States. It has over 6 million active monthly users. The company’s primary focus is the U.S. prescription drug market, where GoodRx has developed a price comparison tool that it aggregates from over 200 billion daily pricing data points, directing consumers toward coupons negotiated between a pharmacy and intermediaries (pharmacy benefit managers ). GoodRx generates revenue by taking a small share of the fees paid by pharmacies to PBMs in exchange for routing consumers to these discount programs, and separately through a subscription-based model (GoodRx Gold), which offers discounted drugs to customers paying a monthly membership fee.
Placing GoodRx Under Review
GoodRx is a consumer-focused digital healthcare platform that aims to lower the cost of healthcare in the United States. It has over 6 million active monthly users. The company’s primary focus is the U.S. prescription drug market, where GoodRx has developed a price comparison tool that it aggregates from over 200 billion daily pricing data points, directing consumers toward coupons negotiated between a pharmacy and intermediaries (pharmacy benefit managers ). GoodRx generates revenue by taking a small share of the fees paid by pharmacies to PBMs in exchange for routing consumers to these discount programs, and separately through a subscription-based model (GoodRx Gold), which offers discounted drugs to customers paying a monthly membership fee.
RatingPrice TargetGoodRx Shares Tumble After Full-Year Guidance Pulled on News of Grocer-PBMs Dispute
GoodRx is a consumer-focused digital healthcare platform that aims to lower the cost of healthcare in the United States. It has over 6 million active monthly users. The company’s primary focus is the U.S. prescription drug market, where GoodRx has developed a price comparison tool that it aggregates from over 200 billion daily pricing data points, directing consumers toward coupons negotiated between a pharmacy and intermediaries (pharmacy benefit managers ). GoodRx generates revenue by taking a small share of the fees paid by pharmacies to PBMs in exchange for routing consumers to these discount programs, and separately through a subscription-based model (GoodRx Gold), which offers discounted drugs to customers paying a monthly membership fee.
RatingPrice TargetGoodRx Shares Tumble After Full-Year Guidance Pulled on News of Grocer-PBMs Dispute
GoodRx is a consumer-focused digital healthcare platform that aims to lower the cost of healthcare in the United States. It has over 6 million active monthly users. The company’s primary focus is the U.S. prescription drug market, where GoodRx has developed a price comparison tool that it aggregates from over 200 billion daily pricing data points, directing consumers toward coupons negotiated between a pharmacy and intermediaries (pharmacy benefit managers ). GoodRx generates revenue by taking a small share of the fees paid by pharmacies to PBMs in exchange for routing consumers to these discount programs, and separately through a subscription-based model (GoodRx Gold), which offers discounted drugs to customers paying a monthly membership fee.
RatingPrice Target